SWNRX Performance — Schwab Target 2050 Fund
Data updated: 2026-09-24
SWNRX returned +9.82% year to date and +19.93% over one year to Jul 2026. Annualised returns are +15.67% over 3 years and +8.47% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $155, against $146 for the category, and to $120 over one year, against $116. Volatility over the past three years was 11.84% a year. In the 12 months to Jul 2026 the fund lost a net $58.1M, and assets reached $341.49M.
SWNRX Growth of $100
What $100 invested in Schwab Target 2050 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | SWNRX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $120 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $155 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $150 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $211 | $186 |
SWNRX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.82% |
| 1 year | +19.93% |
| 3 years (annualised) | +15.67% |
| 5 years (annualised) | +8.47% |
SWNRX Annual Returns
Calendar-year total returns of Schwab Target 2050 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +9.82% |
| 2025 | +19.56% |
| 2024 | +13.95% |
| 2023 | +20.63% |
| 2022 | −19.71% |
| 2021 | +17.78% |
| 2020 | +15.29% |
| 2019 (Aug–Dec) | +7.41% |
SWNRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.1% | +2.1% | −6.3% | +8.2% | +3.8% | 0.0% | −0.8% | — | — | — | — | — |
| 2025 | +3.2% | −0.5% | −3.4% | +0.5% | +4.8% | +4.2% | +0.4% | +3.0% | +3.0% | +1.7% | +0.4% | +0.8% |
| 2024 | 0.0% | +4.2% | +2.9% | −3.8% | +4.4% | +1.5% | +2.0% | +2.3% | +1.6% | −2.3% | +3.9% | −3.2% |
| 2023 | +7.7% | −2.9% | +2.3% | +1.1% | −1.0% | +5.6% | +3.2% | −2.5% | −4.4% | −3.2% | +8.6% | +5.5% |
| 2022 | −5.3% | −3.1% | +1.4% | −7.7% | +0.4% | −8.2% | +7.0% | −4.3% | −9.4% | +6.0% | +7.6% | −4.1% |
| 2021 | −0.3% | +2.8% | +2.3% | +4.4% | +1.4% | +1.4% | +0.9% | +2.3% | −4.1% | +4.3% | −2.4% | +3.7% |
| 2020 | −1.2% | −6.7% | −14.5% | +10.8% | +5.0% | +3.1% | +4.9% | +5.1% | −2.6% | −1.9% | +10.8% | +4.6% |
| 2019 | — | — | — | — | — | — | — | −2.0% | +1.4% | +2.4% | +2.6% | +2.9% |
SWNRX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 11.84%
- 3-year Sharpe ratio: 0.94 (vs 4.5% risk-free rate)
- Best month: +8.63% (Nov 2023)
- Worst month: −6.33% (Mar 2026)
SWNRX Fund Flows
Monthly money in and out of Schwab Target 2050 Fund, from SEC Form N-PORT.
- 12-month net flow: −$58.1M
- 12-month gross sales (incl. reinvestments): $67.6M
- Sales ÷ redemptions: 0.54×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $3.4M | $3.2M | $252K |
| Jun 2026 | $2.6M | $3.6M | −$966K |
| May 2026 | $3.0M | $86.3M | −$83.3M |
| Apr 2026 | $4.6M | $3.2M | $1.5M |
| Mar 2026 | $4.6M | $3.6M | $1.1M |
| Feb 2026 | $6.4M | $3.2M | $3.2M |
| Jan 2026 | $6.4M | $5.0M | $1.4M |
| Dec 2025 | $22.1M | $3.1M | $19.0M |
| Nov 2025 | $3.1M | $3.1M | −$649 |
| Oct 2025 | $3.7M | $2.4M | $1.2M |
| Sep 2025 | $3.3M | $5.4M | −$2.1M |
| Aug 2025 | $4.4M | $3.6M | $754K |
SWNRX Assets Under Management
Net assets of Schwab Target 2050 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $341.49M |
| 2026-04-30 | $414.01M |
| 2026-01-31 | $394.53M |
| 2025-10-31 | $375.75M |
| 2025-07-31 | $348.26M |
| 2025-04-30 | $316.02M |
| 2025-01-31 | $328.94M |
| 2024-10-31 | $314.88M |
| 2024-07-31 | $307.95M |
| 2024-04-30 | $282.04M |
| 2024-01-31 | $271.84M |
| 2023-10-31 | $235.36M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.